Skip to content
10-Q

Quarterly Report

SYNAGEVA BIOPHARMA CORP

0001193125-14-389673

← back to feed
Filed
Oct 30, 2014 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2014 · Oct 24, 2014 33.22M sh
Shares Diluted Q3 2014 · Sep 30, 2014 33.17M sh
Shares Diluted Q3 2014 · Sep 30, 2014 32.54M sh
Shares Diluted Q3 2014 · Sep 30, 2013 27.49M sh
Shares Diluted Q3 2014 · Sep 30, 2013 27.19M sh
Capex Q3 2014 · Sep 30, 2014 $14.04M
Capex Q3 2014 · Sep 30, 2013 $12.31M
Short Term Investments Q3 2014 · Sep 30, 2014 $411.85M
Short Term Investments Q3 2014 · Dec 31, 2013 $346.6M
Cash And Equivalents Q3 2014 · Sep 30, 2014 $76.54M
Cash And Equivalents Q3 2014 · Dec 31, 2013 $62.14M
Cash And Equivalents Q3 2014 · Sep 30, 2013 $216.87M
Cash And Equivalents Q3 2014 · Dec 31, 2012 $23.88M
Stockholders Equity Q3 2014 · Sep 30, 2014 $519.64M
Stockholders Equity Q3 2014 · Dec 31, 2013 $430.2M
Current Liabilities Q3 2014 · Sep 30, 2014 $23.1M
Current Liabilities Q3 2014 · Dec 31, 2013 $13.92M
Total Liabilities Q3 2014 · Sep 30, 2014 $28.57M
Total Liabilities Q3 2014 · Dec 31, 2013 $17.75M
Current Assets Q3 2014 · Sep 30, 2014 $500.13M
Current Assets Q3 2014 · Dec 31, 2013 $416.72M
Total Assets Q3 2014 · Sep 30, 2014 $548.21M
Total Assets Q3 2014 · Dec 31, 2013 $447.95M
Eps Diluted Q3 2014 · Sep 30, 2014 −$1.46
Eps Diluted Q3 2014 · Sep 30, 2014 −$4.15
Eps Diluted Q3 2014 · Sep 30, 2013 −$1.02
Eps Diluted Q3 2014 · Sep 30, 2013 −$2.38
Eps Basic Q3 2014 · Sep 30, 2014 −$1.46
Eps Basic Q3 2014 · Sep 30, 2014 −$4.15
Eps Basic Q3 2014 · Sep 30, 2013 −$1.02
Eps Basic Q3 2014 · Sep 30, 2013 −$2.38
Sga Expense Q3 2014 · Sep 30, 2014 $14.44M
Sga Expense Q3 2014 · Sep 30, 2014 $36.84M
Sga Expense Q3 2014 · Sep 30, 2013 $6.6M
Sga Expense Q3 2014 · Sep 30, 2013 $18.69M
Rd Expense Q3 2014 · Sep 30, 2014 $34.61M
Rd Expense Q3 2014 · Sep 30, 2014 $102M
Rd Expense Q3 2014 · Sep 30, 2013 $22.68M
Rd Expense Q3 2014 · Sep 30, 2013 $54.47M
Net Income Q3 2014 · Sep 30, 2014 −$48.32M
Net Income Q3 2014 · Sep 30, 2014 −$134.98M
Net Income Q3 2014 · Sep 30, 2013 −$28.12M
Net Income Q3 2014 · Sep 30, 2013 −$64.71M
Operating Income Q3 2014 · Sep 30, 2014 −$48.04M
Operating Income Q3 2014 · Sep 30, 2014 −$134.83M
Operating Income Q3 2014 · Sep 30, 2013 −$28.2M
Operating Income Q3 2014 · Sep 30, 2013 −$64.96M
Revenue Q3 2014 · Sep 30, 2014 $1.33M
Revenue Q3 2014 · Sep 30, 2014 $5.26M
Revenue Q3 2014 · Sep 30, 2013 $1.37M
Revenue Q3 2014 · Sep 30, 2013 $9.9M